SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/23/19 BioCardia, Inc. 8-A12B 1:19K RDG Filings/FA |
Document/Exhibit Description Pages Size 1: 8-A12B Registration of a Class of Securities HTML 12K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A |
||||
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 |
BioCardia, Inc. |
(Exact name of Registrant as specified in its charter) |
Delaware |
47-0892881 |
|
(State of incorporation or organization) |
(I.R.S. Employer Identification No.) |
125 Shoreway Road, Suite B, |
(Address of principal executive offices including zip code) |
Securities to be registered pursuant to Section 12(b) of the Act: |
Title of each class to be so registered |
Name of each exchange on which each class is to be registered |
|
Common Stock, par value $0.001 per share Warrants, exercisable for shares of Common Stock |
The Nasdaq Stock Market LLC
The Nasdaq Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act registration statement or Regulation A offering statement file number to which this form relates: Registration Statement No. 333-230779
Securities to be registered pursuant to Section 12(g) of the Act: None
Item 1. Description of Registrant’s Securities to be Registered
BioCardia, Inc. (the “Registrant”) hereby incorporates by reference the description of its common stock, par value $0.001 per share and the warrants exercisable for shares of such common stock, to be registered hereunder contained under the heading “Description of the Securities We Are Offering” in the prospectus forming part of the Registrant’s Registration Statement on Form S-1 (File No. 333-230779), initially filed with the Securities and Exchange Commission (the “Commission”) on April 8, 2019, as amended from time to time (the “Registration Statement”). In addition, any prospectus subsequently filed by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, that constitutes part of the Registration Statement shall be deemed to be incorporated by reference herein.
Item 2. Exhibits
Under the “Instructions as to Exhibits” section of Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are to be registered on The Nasdaq Stock Market LLC and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
BIOCARDIA, INC. |
|||
Date: July 23, 2019 |
By: |
||
Chief Executive Officer |
This ‘8-A12B’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 7/23/19 | S-1/A | ||
4/8/19 | ||||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/14/24 BioCardia, Inc. S-3 4:237K RDG Filings/FA 11/17/23 BioCardia, Inc. 424B5 1:459K RDG Filings/FA 6/22/23 BioCardia, Inc. 424B5 1:431K RDG Filings/FA 12/19/22 BioCardia, Inc. S-3 12/16/22 4:247K RDG Filings/FA 4/12/22 BioCardia, Inc. 424B5 1:422K RDG Filings/FA 3/30/21 BioCardia, Inc. 424B5 1:1.1M RDG Filings/FA 12/16/20 BioCardia, Inc. 424B5 1:466K RDG Filings/FA 12/15/20 BioCardia, Inc. 424B5 1:463K RDG Filings/FA 10/09/20 BioCardia, Inc. S-3 5:1.4M RDG Filings/FA |